https://www.thebodypro.com/author/calvin-cohen

Latest by Calvin Cohen, M.D., M.S.

Promo Image
Lipodystrophy/Body Fat

Dyslipidemia: Change to Tenofovir?

For the past few years, studies have increasingly highlighted the contribution of at least some of the nucleosides to increases in lipids, such as total cholesterol and triglycerides. Most recently, the Gilead 903 study comparing tenofovir (TDF, Vire...

Promo Image
Lipodystrophy/Body Fat

Little Lipodystrophy Seen With Either Atazanavir or Efavirenz

Atazanavir and Efavirenz Have Similar Effects on Body Fat Distribution in Antiretroviral-Naive Patients When Combined With Fixed-Dose Zidovudine and Lamivudine: 48-Week Results From the Metabolic Substudy of BMS AI424-034 (Oral LB13) Authored b...

Promo Image

More Results Reported on Study 903: Tenofovir + 3TC + Efavirenz Vs. d4T + 3TC + Efavirenz

Characterization of Virologic Failure Through 96 Weeks Among Treatment-Naive Patients Taking Tenofovir DF (TDF) or Stavudine (d4T) in Combination With Lamivudine (3TC) and Efavirenz (EFV) (Poster 553) Authored by M.D. Miller, N.A. Margot, D.J. ...

Promo Image

CROI 2003: When, and With What, to Initiate Antiretroviral Treatment

One of the ongoing themes of all AIDS conferences is how they inform decision making for two of the most pivotal treatment issues in the life of someone with HIV: when to initiate antiviral treatment, and with what regimen.

Like almost all prior mee...

Promo Image

Lack of Interaction Between Stavudine Extended-Release Formulation and Tenofovir Disoproxil Fumarate

Lack of Interaction Between Stavudine Extended-Release Formulation (d4T XR) and Tenofovir Disoproxil Fumarate (TDF) (Poster 534) Authored by S. Kaul, K. Bassi, B. Damle, R. Smith, J. Gale, E. O'Mara, U. Chaudhari, K. Ryan View the original ...

Promo Image

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Stavudine When Used in Combination With Lamivudine and Efavirenz in HIV-1 Infected Patients Naive to Antiretroviral Therapy: 48-Week Interim Results

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) Versus Stavudine (d4T) When Used in Combination With Lamivudine (3TC) and Efavirenz (EFV) in HIV-1 Infected Patients Naive to Antiretroviral Therapy (ART): 48-Week Interim Results (LbOr17) ...

Promo Image

Treatment Interruptions: A Summary of the Data to Date

Structured Treatment Interruptions (STI) in Patients Receiving HAART Within 90 Days After Onset of Primary HIV-1 Infection (PHI) Symptoms: Spontaneous Control of Viremia in Only One Third of Cases After Four Cycles Off Therapy (ThOrB1437) Autho...

Promo Image

Retrospective Analysis of the Use of Tenofovir DF in a Private Practice

Retrospective Analysis of the Use of Tenofovir DF in a Private Practice (MoPeA3005) Authored by E. DeJesus, R. Ortiz, R.T. AndersonView the original abstract

Since the approval of tenofovir, there has been interest in the potential for its use...

Promo Image

Are Episodes of Transient Viremia ("Blips" in HIV RNA) Predictive of Virologic Failure in Heavily Treatment-Experienced Patients?

Are Episodes of Transient Viremia ("Blips" in HIV RNA) Predictive of Virologic Failure in Heavily Treatment-Experienced Patients? Abstract 93 Authored by D. Havlir1, R. Bassett2, V. DeGruttola2, S. Hammer3, R. Gulick4, and J. Mellors5 for t...

Promo Image

Emerging Complications of HIV Therapy

Emerging Complications of HIV Therapy Abstract 1321 Authored by William G. Powderly (Washington Univ. Sch. of Med., St. Louis, MO) View the original abstract

In the past years, the side effects of HIV treatments have emerged as a compe...